Optomed Plc Board Member Seppo Mäkinen Engages in Share Transaction

Seppo Mäkinen, a member of the Board of Directors at Optomed Plc, has acquired shares in the company. The transaction took place on August 13, 2026, marking his first notification-obligated share transaction. This information was disclosed in a regulatory filing concerning the transaction.

Mäkinen serves as both a member and deputy member of Optomed's Board. Specific details regarding the volume or value of the transaction have not yet been publicly released. The transaction is registered under the name "Mäkinen, Seppo" and is classified as an initial notification.

Optomed Plc is a health technology company specializing in the diagnostics and screening of eye diseases. The company has developed imaging devices and software solutions for fundus imaging, aiding in the early detection of conditions like diabetic retinopathy and glaucoma. Transactions by company insiders can provide market indicators regarding the firm's outlook.

The transaction was announced on August 14, 2026, at 13:00 Helsinki time. Mäkinen's position on the board grants him access to inside information, but mandatory disclosures ensure market transparency and fairness.